Board of Trustees
James Whitlock, MD
James Whitlock, MD, is the Division Head of Hematology/Oncology and the Women’s Auxiliary Millennium Chair in Hematology/Oncology at The Hospital for Sick Children, and Professor of Pediatrics at the University of Toronto.
Dr. Whitlock graduated cum laude from Southwestern University at Memphis with a degree in Biology, earned his medical degree from the Vanderbilt University School of Medicine, and completed his Pediatrics residency and fellowship in the Division of Pediatric Hematology-Oncology at Vanderbilt under the mentorship of Dr. John N. Lukens, Jr. In 1990, Dr. Whitlock joined the Vanderbilt faculty, where he held the position of Craig-Weaver Professor of Pediatrics. After 30 years at Vanderbilt, he relocated to Canada to join the Hospital for Sick Children.
Dr. Whitlock’s honors and awards include membership in Phi Beta Kappa and the Alpha Omega Alpha Medical Honor Society, the David T. Karzon Award for outstanding research during residency, and the Gilda’s Club Spirit of Gilda Award. He has been recognized by America’s Top Doctors and The Best Doctors in America, and has authored or co-authored more than 80 journal articles and book chapters.
Dr. Whitlock’s research interests include the biology and treatment of childhood acute leukemias, the development of new drugs for the treatment of childhood cancers, and the biology and treatment of Langerhans cell histiocytosis and other histiocytic disorders. He is a member of the Children’s Oncology Group Acute Lymphocytic Leukemia Executive Committee and Vice Chair for New Agents and Relapse, and has served as Chair or Vice-Chair of several additional national clinical trials and strategic committees. He also has served as a committee member for a number of other national and international organizations, including the American Society of Clinical Oncology and the American Society of Pediatric Hematology/Oncology. In addition to being a member of the Board of Trustees of the Histiocytosis Association, Dr. Whitlock serves as President of the Executive Board of the Histiocyte Society.
Dr. Whitlock’s interests in histiocytosis stem from his involvement with several challenging patients, including identical twins with refractory infantile Langerhans cell histiocytosis (both of whom are now thriving teenagers), and a child with an atypical presentation of HLH (who is now doing well several years after an unrelated bone marrow transplant). The challenges in managing these difficult cases led to interactions with other physicians who share his interest in histiocytosis, and to his current involvement with both the Histiocytosis Association and the Histiocyte Society. Dr. Whitlock says the opportunity to provide assistance to children and adults with these difficult diseases, and his involvement with the Association and the Society, have been among the most rewarding aspects of his career.